Nakamura Toshiyuki, Shibata Norihito, Nishimoto-Shibata Takako, Feng Dongdong, Ikemoto Mamoru, Motojima Kiyoto, Iso-O Naoyuki, Tsukamoto Kazuhisa, Tsujimoto Masafumi, Arai Hiroyuki
Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13404-9. doi: 10.1073/pnas.0506679102. Epub 2005 Sep 8.
Scavenger receptor class B type I (SR-BI) is a high-density lipoprotein (HDL) receptor that mediates the selective uptake of HDL cholesterol and cholesterol secretion into bile in the liver. Previously, we identified an SR-BI-associated protein, termed PDZK1, from rat liver membrane extracts. PDZK1 contains four PSD-95/Dlg/ZO-1 (PDZ) domains, the first of which in the N-terminal region is responsible for the association with SR-BI. PDZK1 controls hepatic SR-BI expression in a posttranscriptional fashion both in cell culture and in vivo. In this study, we demonstrated that the C-terminal region of PDZK1 is crucial for up-regulating SR-BI protein expression. Metabolic labeling experiments and phosphoamino acid analysis revealed that PDZK1 is phosphorylated at Ser residues within this region. Point-mutation analysis demonstrated that PDZK1 is phosphorylated at Ser-509. Interestingly, a mutant PDZK1, in which Ser-509 was replaced with Ala, lost the ability to up-regulate SR-BI protein. We identified Ser-509 of PDZK1 as the residue that is phosphorylated by the cAMP-dependent PKA in vitro as well as in cell culture. Ser-509 of PDZK1 in rat liver was also phosphorylated, as shown by an Ab that specifically detects phosphorylated Ser-509. Administration of glucagon to Wistar rats increased PDZK1 phosphorylation as well as hepatic SR-BI and PDZK1 expression while it decreased plasma HDL levels, indicating that PDZK1 phosphorylation is hormonally regulated. These findings suggest that phosphorylation of PDZK1 has an important role in the regulation of hepatic SR-BI expression and, thus, influences plasma HDL levels.
I型清道夫受体B类(SR-BI)是一种高密度脂蛋白(HDL)受体,介导HDL胆固醇的选择性摄取以及肝脏中胆固醇向胆汁的分泌。此前,我们从大鼠肝细胞膜提取物中鉴定出一种与SR-BI相关的蛋白,称为PDZK1。PDZK1包含四个PSD-95/Dlg/ZO-1(PDZ)结构域,其中位于N端区域的第一个结构域负责与SR-BI结合。在细胞培养和体内实验中,PDZK1均以转录后方式调控肝脏中SR-BI的表达。在本研究中,我们证明PDZK1的C端区域对于上调SR-BI蛋白表达至关重要。代谢标记实验和磷酸氨基酸分析表明,PDZK1在该区域内的丝氨酸残基处发生磷酸化。点突变分析表明,PDZK1在Ser-509处发生磷酸化。有趣的是,将Ser-509替换为丙氨酸的突变型PDZK1失去了上调SR-BI蛋白的能力。我们确定PDZK1的Ser-509是在体外以及细胞培养中被cAMP依赖性蛋白激酶A(PKA)磷酸化的残基。如一种特异性检测磷酸化Ser-509的抗体所示,大鼠肝脏中PDZK1的Ser-509也发生了磷酸化。给Wistar大鼠注射胰高血糖素可增加PDZK1的磷酸化以及肝脏中SR-BI和PDZK1的表达,同时降低血浆HDL水平,这表明PDZK1的磷酸化受激素调节。这些发现提示,PDZK1的磷酸化在肝脏SR-BI表达的调控中具有重要作用,进而影响血浆HDL水平。